InvestorsHub Logo
Followers 33
Posts 2841
Boards Moderated 2
Alias Born 10/24/2015

Re: NY1972 post# 296

Monday, 06/12/2023 7:01:54 PM

Monday, June 12, 2023 7:01:54 PM

Post# of 394
If they could upend auto BCMA and/or CD19 CARs, I think it might.

As for HER2, that is partnered with Ono Pharma, a CAR-T, with several edits (CAR uses a CD28zeta mutant that contains one instead of all three iTAMs, TCR knockout, high-affinity and non-cleavable CD16 receptor, IL-7 receptor, CD38 knockout, TGF-R 'switch' receptor, and CXCR2 chemokine receptor).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News